By 
Last year, Apple faced a patent dispute with medical technology company Masimo, which resulted in a ban on selling the Watch Series 9 and Watch Ultra 2 in the US. However, Apple was granted a temporary stay on the ban, which allowed them to continue selling their latest smartwatches.
Starting January 18, Apple Watch Series 9 and Apple Watch Ultra 2 models will be sold in the U.S. without the Blood Oxygen feature, as reported by 9to5Mac’s Chance Miller. This move allows Apple to avoid a sales ban on these models. The change will occur at Apple’s online store in the U.S. starting at 6 a.m. Pacific Time.
According to the report, certain models of Apple Watch will still have the Blood Oxygen app available. However, when users attempt to access the app, they will receive a message stating that the app has been discontinued. The message will direct users to learn more about the discontinuation of the Health app on their iPhone, with a link to a support article on Apple’s website.
Apple has confirmed that the Blood Oxygen app will continue to work on previously purchased Series 9 and Ultra 2 devices. The feature will also continue to work on Apple Watches that are sold outside of the United States and will not be impacted by the sales prohibition.
Comments